MCM
MRK icon

McRae Capital Management’s Merck MRK Stock Holding History

McRae Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
8,069
-200
-2% -$23.4K 0.2% 53
2026
Q1 		$995K Hold
8,269
– – 0.21% 52
2025
Q4 		$870K Sell
8,269
-289
-3% -$27.1K 0.18% 51
2025
Q3 		$718K Hold
8,558
– – 0.14% 56
2025
Q2 		$677K Buy
8,558
+200
+2% +$15.9K 0.14% 56
2025
Q1 		$750K Sell
8,358
-300
-3% -$28K 0.16% 54
2024
Q4 		$861K Sell
8,658
-300
-3% -$30.9K 0.17% 49
2024
Q3 		$1.02M Sell
8,958
-111
-1% -$13.2K 0.2% 45
2024
Q2 		$1.12M Sell
9,069
-126
-1% -$16.2K 0.26% 40
2024
Q1 		$1.21M Sell
9,195
-142
-2% -$17.5K 0.27% 41
2023
Q4 		$1.02M Buy
9,337
+157
+2% +$16.3K 0.25% 42
2023
Q3 		$945K Sell
9,180
-346
-4% -$37.3K 0.28% 42
2023
Q2 		$1.1M Buy
9,526
+38
+0.4% +$4.32K 0.31% 39
2023
Q1 		$1.01M Sell
9,488
-36
-0.4% -$3.89K 0.29% 41
2022
Q4 		$1.06M Buy
9,524
+94
+1% +$9.61K 0.31% 43
2022
Q3 		$812K Buy
9,430
+281
+3% +$25.1K 0.25% 44
2022
Q2 		$834K Buy
9,149
+379
+4% +$33.6K 0.23% 49
2022
Q1 		$720K Buy
8,770
+1,416
+19% +$112K 0.16% 54
2021
Q4 		$564K Buy
7,354
+182
+3% +$14.5K 0.12% 64
2021
Q3 		$539K Sell
7,172
-263
-4% -$20K 0.12% 65
2021
Q2 		$578K Sell
7,435
-381
-5% -$28.3K 0.13% 62
2021
Q1 		$575K Buy
7,816
+436
+6% +$32.2K 0.14% 60
2020
Q4 		$576K Buy
7,380
+427
+6% +$32.7K 0.17% 57
2020
Q3 		$550K Buy
6,953
+110
+2% +$8.62K 0.18% 58
2020
Q2 		$505K Sell
6,843
-275
-4% -$20.7K 0.19% 57
2020
Q1 		$523K Buy
7,118
+4
+0.1% +$314 0.26% 45
2019
Q4 		$617K Sell
7,114
-205
-3% -$16.8K 0.23% 53
2019
Q3 		$588K Buy
7,319
+129
+2% +$10.3K 0.23% 49
2019
Q2 		$575K Buy
7,190
+737
+11% +$56.4K 0.23% 50
2019
Q1 		$512K Sell
6,453
-53
-0.8% -$3.96K 0.21% 56
2018
Q4 		$474K Buy
6,506
+388
+6% +$27.4K 0.24% 51
2018
Q3 		$414K Sell
6,118
-189
-3% -$12K 0.18% 64
2018
Q2 		$365K Sell
6,307
-1,850
-23% -$104K 0.15% 72
2018
Q1 		$424K Buy
8,157
+2,322
+40% +$125K 0.19% 59
2017
Q4 		$313K Hold
5,835
– – 0.13% 75
2017
Q3 		$357K Sell
5,835
-419
-7% -$25.4K 0.15% 67
2017
Q2 		$383K Buy
6,254
+262
+4% +$15.9K 0.16% 63
2017
Q1 		$363K Sell
5,992
-1,750
-23% -$106K 0.15% 65
2016
Q4 		$435K Sell
7,742
-43
-0.6% -$2.52K 0.19% 59
2016
Q3 		$464K Buy
7,785
+11
+0.1% +$643 0.21% 54
2016
Q2 		$427K Sell
7,774
-378
-5% -$20.1K 0.2% 58
2016
Q1 		$412K Buy
8,152
+2,199
+37% +$108K 0.18% 57
2015
Q4 		$300K Hold
5,953
– – 0.14% 62
2015
Q3 		$281K Sell
5,953
-10,480
-64% -$557K 0.14% 62
2015
Q2 		$893K Sell
16,433
-314
-2% -$17.6K 0.42% 35
2015
Q1 		$919K Sell
16,747
-419
-2% -$23.7K 0.42% 35
2014
Q4 		$930K Buy
17,166
+84
+0.5% +$4.68K 0.43% 35
2014
Q3 		$966K Sell
17,082
-210
-1% -$11.8K 0.47% 35
2014
Q2 		$955K Sell
17,292
-105
-0.6% -$5.73K 0.46% 35
2014
Q1 		$942K Hold
17,397
– – 0.48% 35
2013
Q4 		$831K Hold
17,397
– – 0.43% 34
2013
Q3 		$790K Sell
17,397
-2,201
-11% -$100K 0.44% 34
2013
Q2 		$869K Buy
+19,598
New +$875K 0.51% 34

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

McRae Capital Management's MRK Position: Q2 2026 in Review

McRae Capital Management reduced its Merck (MRK) stake by 2.4% in Q2 2026, selling an estimated $23.4K and leaving 8,069 shares worth $1.04M. The position accounts for 0.2% of the portfolio, ranked #53.

McRae Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.21M in Q1 2024. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • McRae Capital Management held 8,069 shares of Merck worth $1.04M as of Q2 2026.
  • McRae Capital Management sold 200 Merck shares in Q2 2026, an estimated $23.4K.
  • Merck made up 0.2% of McRae Capital Management's portfolio in Q2 2026, its #53 holding.
  • McRae Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • McRae Capital Management's Merck position peaked at $1.21M in Q1 2024.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.